{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:28:54Z","timestamp":1780093734617,"version":"3.54.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004203","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["P.SI.015.5"],"award-info":[{"award-number":["P.SI.015.5"]}],"id":[{"id":"10.13039\/501100004203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11307-019-01393-8","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T21:36:24Z","timestamp":1562621784000},"page":"549-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Fluorine-19 Cellular MRI Detection of In Vivo Dendritic Cell Migration and Subsequent Induction of Tumor Antigen-Specific Immunotherapeutic Response"],"prefix":"10.1007","volume":"22","author":[{"given":"Corby","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Makela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Dekaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"issue":"Suppl 8","key":"1393_CR1","doi-asserted-by":"crossref","first-page":"viii22","DOI":"10.1093\/annonc\/mds259","volume":"23","author":"WR Gerritsen","year":"2012","unstructured":"Gerritsen WR (2012) The evolving role of immunotherapy in prostate cancer. Ann Oncol 23(Suppl 8):viii22\u2013viii27","journal-title":"Ann Oncol"},{"key":"1393_CR2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood-2009-11-251884","volume":"116","author":"G Schreibelt","year":"2010","unstructured":"Schreibelt G, Benitez-Ribas D, Schuurhuis D et al (2010) Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells. Blood 116:564\u2013574","journal-title":"Blood"},{"issue":"12","key":"1393_CR3","doi-asserted-by":"crossref","first-page":"a028472","DOI":"10.1101\/cshperspect.a028472","volume":"10","author":"Thomas A. Waldmann","year":"2017","unstructured":"Waldmann TA (2018) Cytokines in cancer immunotherapy. Cold Spring Harb Perspect Biol 10:","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1393_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.it.2012.02.007","volume":"33","author":"R Forster","year":"2012","unstructured":"Forster R, Braun A, Worbs T (2012) Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol 33:271\u2013280","journal-title":"Trends Immunol"},{"key":"1393_CR5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.20030448","volume":"198","author":"A Martin-Fontecha","year":"2003","unstructured":"Martin-Fontecha A, Sebastiani S, Hopken UE et al (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198:615\u2013621","journal-title":"J Exp Med"},{"key":"1393_CR6","first-page":"2859","volume":"10","author":"B Wang","year":"2018","unstructured":"Wang B, Sun C, Wang S et al (2018) Mouse dendritic cell migration in abdominal lymph nodes by intraperitoneal administration. Am J Transl Res 10:2859\u20132867","journal-title":"Am J Transl Res"},{"key":"1393_CR7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2326-6066.CIR-15-0189","volume":"4","author":"E Scheid","year":"2016","unstructured":"Scheid E, Major P, Bergeron A et al (2016) Tn-MUC1 DC vaccination of rhesus macaques and a phase I\/II trial in patients with nonmetastatic castrate-resistant prostate cancer. Cancer Immunol Res 4:881\u2013892","journal-title":"Cancer Immunol Res"},{"key":"1393_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4161\/onci.18628","volume":"1","author":"LT Blalock","year":"2012","unstructured":"Blalock LT, Landsberg J, Messmer M et al (2012) Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity. Oncoimmunology 1:287\u2013357","journal-title":"Oncoimmunology"},{"key":"1393_CR9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2013.00454","volume":"4","author":"LH Butterfield","year":"2013","unstructured":"Butterfield LH (2013) Dendritic cells in cancer immunotherapy clinical trials: are we making progress? Front Immunol 4:454","journal-title":"Front Immunol"},{"key":"1393_CR10","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1158\/1078-0432.CCR-08-2729","volume":"15","author":"P Verdijk","year":"2009","unstructured":"Verdijk P, Aarntzen EH, Lesterhuis WJ et al (2009) Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 15:2531\u20132540","journal-title":"Clin Cancer Res"},{"key":"1393_CR11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/mrm.25454","volume":"72","author":"ET Ahrens","year":"2014","unstructured":"Ahrens ET, Helfer BM, O\u2019Hanlon CF, Schirda C (2014) Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med 72:1696\u20131701","journal-title":"Magn Reson Med"},{"key":"1393_CR12","doi-asserted-by":"crossref","first-page":"e0118544","DOI":"10.1371\/journal.pone.0118544","volume":"10","author":"JM Gaudet","year":"2015","unstructured":"Gaudet JM, Ribot EJ, Chen Y et al (2015) Tracking the fate of stem cell implants with fluorine-19 MRI. PLoS One 10:e0118544","journal-title":"PLoS One"},{"key":"1393_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/wnan.1227","volume":"5","author":"GA Dekaban","year":"2013","unstructured":"Dekaban GA, Hamilton AM, Fink CA et al (2013) Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Wires Nanomed Nanobi 5:469\u2013483","journal-title":"Wires Nanomed Nanobi"},{"key":"1393_CR14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11307-010-0403-0","volume":"13","author":"R Rohani","year":"2011","unstructured":"Rohani R, de Chickera SN, Willert C et al (2011) In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles. Mol Imaging Biol 13:679\u2013694","journal-title":"Mol Imaging Biol"},{"key":"1393_CR15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CJI.0b013e318197b2a0","volume":"32","author":"GA Dekaban","year":"2009","unstructured":"Dekaban GA, Snir J, Shrum B et al (2009) Semiquantitation of mouse dendritic cell migration in vivo using cellular MRI. J Immunother 32:240\u2013251","journal-title":"J Immunother"},{"key":"1393_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ijc.25672","volume":"129","author":"F Bonetto","year":"2011","unstructured":"Bonetto F, Srinivas M, Heerschap A et al (2011) A novel 19F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer 129:365\u2013373","journal-title":"Int J Cancer"},{"key":"1393_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40425-018-0416-9","volume":"6","author":"F Chapelin","year":"2018","unstructured":"Chapelin F, Capitini CM, Ahrens ET (2018) Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer. J Immunother Cancer 6:105","journal-title":"J Immunother Cancer"},{"key":"1393_CR18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41598-017-19031-0","volume":"8","author":"C Fink","year":"2018","unstructured":"Fink C, Gaudet JM, Fox MS et al (2018) 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting. Sci Rep 8:590","journal-title":"Sci Rep"},{"key":"1393_CR19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba K, Inaba M, Romani N et al (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J Exp Med 176:1693\u20131702","journal-title":"J Exp Med"},{"key":"1393_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/intimm\/dxr095","volume":"24","author":"S de Chickera","year":"2012","unstructured":"de Chickera S, Willert C, Mallet C et al (2012) Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes. Int Immunol 24:29\u201341","journal-title":"Int Immunol"},{"key":"1393_CR21","doi-asserted-by":"crossref","first-page":"e0187314","DOI":"10.1371\/journal.pone.0187314","volume":"12","author":"S Sethumadhavan","year":"2017","unstructured":"Sethumadhavan S, Silva M, Philbrook P et al (2017) Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells. PLoS One 12:e0187314","journal-title":"PLoS One"},{"key":"1393_CR22","doi-asserted-by":"crossref","first-page":"8830","DOI":"10.1016\/j.biomaterials.2012.08.048","volume":"33","author":"M Srinivas","year":"2012","unstructured":"Srinivas M, Boehm-Sturm P, Figdor CG et al (2012) Labeling cells for in vivo tracking using 19F MRI. Biomaterials 33:8830\u20138840","journal-title":"Biomaterials"},{"key":"1393_CR23","doi-asserted-by":"crossref","first-page":"e0163704","DOI":"10.1371\/journal.pone.0163704","volume":"11","author":"AJ Taylor","year":"2016","unstructured":"Taylor AJ, Granwehr J, Lesbats C et al (2016) Probe-specific procedure to estimate sensitivity and detection limits for 19F magnetic resonance imaging. PLoS One 11:e0163704","journal-title":"PLoS One"},{"key":"1393_CR24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mrm.21352","volume":"58","author":"M Srinivas","year":"2007","unstructured":"Srinivas M, Morel PA, Ernst LA et al (2007) Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 58:725\u2013734","journal-title":"Magn Reson Med"},{"key":"1393_CR25","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/mrm.22702","volume":"65","author":"TK Hitchens","year":"2011","unstructured":"Hitchens TK, Ye Q, Eytan DF et al (2011) 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med 65:1144\u20131153","journal-title":"Magn Reson Med"},{"key":"1393_CR26","doi-asserted-by":"crossref","unstructured":"Makela AV, Foster PJ (2018) Pre-clinical 19F MRI cell tracking at 3 Tesla. Magma","DOI":"10.1007\/s10334-018-0715-7"},{"key":"1393_CR27","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1158\/0008-5472.CAN-08-3691","volume":"69","author":"CM Long","year":"2009","unstructured":"Long CM, van Laarhoven HW, Bulte JW, Levitsky HI (2009) Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res 69:3180\u20133187","journal-title":"Cancer Res"},{"key":"1393_CR28","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.2217\/nnm.15.76","volume":"10","author":"M Srinivas","year":"2015","unstructured":"Srinivas M, Tel J, Schreibelt G et al (2015) PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI. Nanomedicine (London) 10:2339\u20132348","journal-title":"Nanomedicine (London)"},{"key":"1393_CR29","doi-asserted-by":"crossref","first-page":"e1143996","DOI":"10.1080\/2162402X.2016.1143996","volume":"5","author":"MN Bouchlaka","year":"2016","unstructured":"Bouchlaka MN, Ludwig KD, Gordon JW et al (2016) 19F-MRI for monitoring human NK cells in vivo. Oncoimmunology 5:e1143996","journal-title":"Oncoimmunology"},{"issue":"2","key":"1393_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1148\/radiol.15142849","volume":"275","author":"Noriko Sato","year":"2015","unstructured":"Sato N, Wu H, Asiedu KO et al (2015) 89Zr-oxine complex PET cell imaging in monitoring cell-based therapies. Radiology 275:490\u2013500","journal-title":"Radiology"},{"key":"1393_CR31","doi-asserted-by":"crossref","unstructured":"Wimmers F, Schreibelt G, Skold AE et al (2014) Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets. Front Immunol 5:165","DOI":"10.3389\/fimmu.2014.00165"},{"issue":"2","key":"1393_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","volume":"193","author":"Madhav V. Dhodapkar","year":"2001","unstructured":"Dhodapkar MV, Steinman RM, Krasovsky J et al (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233\u2013238","journal-title":"The Journal of Experimental Medicine"},{"key":"1393_CR33","doi-asserted-by":"crossref","unstructured":"de Chickera SN, Snir J, Willert C et al (2011) Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI. Contrast Media Mol I 6:314\u2013327","DOI":"10.1002\/cmmi.433"},{"issue":"10","key":"1393_CR34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nri3531","volume":"13","author":"Eric T. Ahrens","year":"2013","unstructured":"Ahrens ET, Bulte JW (2013) Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 13:755\u2013763","journal-title":"Nature Reviews Immunology"},{"issue":"22","key":"1393_CR35","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1158\/0008-5472.CAN-03-3251","volume":"64","author":"Ronald J. C. L. M. Vuylsteke","year":"2004","unstructured":"Vuylsteke RJ, Molenkamp BG, Gietema HA et al (2004) Local administration of granulocyte\/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma. Cancer Res 64:8456\u20138460","journal-title":"Cancer Research"},{"issue":"4","key":"1393_CR36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1523-1747.1999.00629.x","volume":"113","author":"Kaoru Takayama","year":"1999","unstructured":"Takayama K, Yokozeki H, Ghoreishi M et al (1999) IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression. J Invest Dermatol 113:541\u2013546","journal-title":"Journal of Investigative Dermatology"},{"issue":"10","key":"1393_CR37","doi-asserted-by":"crossref","first-page":"e0164557","DOI":"10.1371\/journal.pone.0164557","volume":"11","author":"Christine Gonzales","year":"2016","unstructured":"Gonzales C, Yoshihara HA, Dilek N et al (2016) In vivo detection and tracking of T cells in various organs in a melanoma tumor model by 19F-fluorine MRS\/MRI. PLoS One 11:e0164557","journal-title":"PLOS ONE"},{"issue":"1","key":"1393_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.2830160103","volume":"16","author":"Oswaldo Castro","year":"1984","unstructured":"Castro O, Nesbitt AE, Lyles D (1984) Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function. Am J Hematol 16:15\u201321","journal-title":"American Journal of Hematology"},{"issue":"2","key":"1393_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"Gavin P. Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137\u2013148","journal-title":"Immunity"},{"issue":"3","key":"1393_CR40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/mrm.22063","volume":"62","author":"Mangala Srinivas","year":"2009","unstructured":"Srinivas M, Turner MS, Janjic JM et al (2009) In vivo cytometry of antigen-specific T cells using 19F MRI. Magn Reson Med 62:747\u2013753","journal-title":"Magnetic Resonance in Medicine"},{"issue":"1","key":"1393_CR41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2016.01.021","volume":"374","author":"Amir Dashti","year":"2016","unstructured":"Dashti A, Ebrahimi M, Hadjati J et al (2016) Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses. Cancer Lett 374:175\u2013185","journal-title":"Cancer Letters"},{"key":"1393_CR42","doi-asserted-by":"crossref","unstructured":"Damo M, Wilson DS, Simeoni E, Hubbell JA (2015) TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma. Sci Rep 5:17622","DOI":"10.1038\/srep17622"},{"key":"1393_CR43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.biopha.2017.10.099","volume":"97","author":"Yan Zhang","year":"2018","unstructured":"Zhang Y, Liu X, Wang R et al (2018) Comparison of fusion protein and DC vaccine in inhibition of mouse B16F10 melanoma tumor. Biomed Pharmacother 97:784\u2013792","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"12","key":"1393_CR44","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","volume":"27","author":"Helmut Jonuleit","year":"1997","unstructured":"Jonuleit H, Kuhn U, Muller G et al (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27:3135\u20133142","journal-title":"European Journal of Immunology"},{"issue":"9","key":"1393_CR45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","volume":"11","author":"Ignacio Melero","year":"2014","unstructured":"Melero I, Gaudernack G, Gerritsen W et al (2014) Therapeutic vaccines for cancer: an overview of clinical trials. Nat Rev Clin Oncol 11:509\u2013524","journal-title":"Nature Reviews Clinical Oncology"},{"key":"1393_CR46","doi-asserted-by":"crossref","unstructured":"Farhood B, Najafi M, Mortezaee K (2019) CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol 234:8509\u20138521","DOI":"10.1002\/jcp.27782"},{"key":"1393_CR47","doi-asserted-by":"crossref","unstructured":"Steitz J, Bruck J, Steinbrink K et al (2000) Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer 86:89\u201394","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I"},{"issue":"5","key":"1393_CR48","first-page":"669-683.e5","volume":"32","author":"Asis Palazon","year":"2017","unstructured":"Palazon A, Tyrakis PA, Macias D et al (2017) An HIF-1alpha\/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell 32:669\u2013683","journal-title":"Cancer Cell"},{"issue":"10","key":"1393_CR49","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1080\/21645515.2016.1197453","volume":"12","author":"Steve Boudewijns","year":"2016","unstructured":"Boudewijns S, Bloemendal M, Gerritsen WR et al (2016) Dendritic cell vaccination in melanoma patients: from promising results to future perspectives. Hum Vacc Immunother 12:2523\u20132528","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"3","key":"1393_CR50","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ajpath.2012.06.002","volume":"181","author":"Anna I. Hooijkaas","year":"2012","unstructured":"Hooijkaas AI, Gadiot J, van der Valk M et al (2012) Targeting BRAFV600E in an inducible murine model of melanoma. Am J Pathol 181:785-794","journal-title":"The American Journal of Pathology"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-019-01393-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T23:19:19Z","timestamp":1594077559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-019-01393-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s11307-019-01393-8","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"8 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}